Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $58.21M.
ENTERPRISE VALUE (EV)
$58.21M
Talphera, Inc.
Market Cap
$57.61M
Enterprise Value (EV)
$58.21M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Talphera, Inc. (TLPH) | $57.61M | $58.21M |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | $37.55M |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | $16.29M |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | $30.59M |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | $49.48M |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | $38.15M |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | $57.21M |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | $41.42M |
| Aldeyra The (ALDX)vs › | $55.25M | $10.30M |
Market Cap
$57.61M
Total Debt
$6.50M
Cash
$5.89M
Enterprise Value
$58.21M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
